Multiple Sclerosis Drugs Market 2017 to 2025 – Share, analysis, Trends and Forecast by Acute Market Reports

PR Comments Off on Multiple Sclerosis Drugs Market 2017 to 2025 – Share, analysis, Trends and Forecast by Acute Market Reports

Multiple Sclerosis Drugs Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 the global multiple sclerosis drugs market was valued at US$ 16.13 Bn in 2016, and is expected to reach US$ 27.38 Bn by 2025, expanding at a CAGR of 6.3% from 2017 to 2025.

Browse Full Report Here: http://www.acutemarketreports.com/report/multiple-sclerosis-drugs-market

Market Insights

Multiple sclerosis (MS) is a chronic demyelinating inflammatory disease of the central nervous system. MS is the most common neurological disease in adult and women; it is estimated that 2.3 million people in the world are affected with multiple sclerosis. For the purpose of study, global MS drugs market is segmented on the basis of molecule type such as biologics and small molecule. It is studied that, in the base year 2016, biologics held largest market share growth mainly driven by Avonex, Betaseron, CinnoVex, Extavia, Rebif, and Tysabri. However, it is also estimated that small molecule will be fastest growing segment due to the expected launch of small molecules such as ALKS-8700, OS-440, RPC-1063, ACT-128800 and BAF312.

Browse the complete report at: http://www.acutemarketreports.com/report/multiple-sclerosis-drugs-market

MS drugs market is segmented on the basis of route of administration such as oral and parenteral route therapeutics. Currently, parenteral MS drugs held the largest market share. The growth of this segment is mainly driven by sales of Avonex, Betaseron, Copaxone, Extavia, Glatopa, Plegridy, Rebif, Zinbryta. Geographically, North America held largest MS drugs market share and it is estimated that it will also show fastest growth during forecast period. Rising incidence of MS, technological advances, and higher cost of treatment medication are prime factors that facilitating the growth of MS drugs market in North America. According to the Multiple Sclerosis Foundation, more than 400,000 people in the United States have MS, and about 200 new cases are diagnosed each week in the United States.

Download Free Request Sample: http://www.acutemarketreports.com/request-free-sample/42923

Market Competition Assessment:

The global multiple sclerosis drugs market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Bayer HealthCare, Biogen, Novartis, Teva, Genzyme (Sanofi), Acorda Therapeutics, Pfizer, GlaxoSmithKline, Acorda Therapeutics, Inc., Merck Serono, Abbvie Inc. and others.

Key Market Movements:

– Factors such as rising prevalence of multiple sclerosis in some countries and higher treatment compliance are driving the growth of MS drugs market.
– Due to the high unmet needs, vendors in the market are focusing in development of ideal treatment, and promising pipeline molecule. Further increase in incidence of MS would fuel the growth of MS drugs market during forecast period.
– Unknown etiology of the disease, difficulties in disease diagnosis and adverse effect of MS medication would negatively impact the growth of MS drugs market.

Latest Reports :
http://www.acutemarketreports.com/report/command-and-control-system-market

http://www.acutemarketreports.com/report/umbilical-cord-blood-banking-market

http://www.acutemarketreports.com/report/airway-management-devices-market
About – Acute Market Reports:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Contact Us:

Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com

Author

Back to Top